Jamaica vs Late-demographic dividend: Immunization, HepB3
Jamaica
99.0%
in 2024
Late-demographic dividend
94.0%
in 2024
Jamaica rank
1st
Late-demographic dividend rank
3rd
Immunization, HepB3 over time
- Jamaica
- Late-demographic dividend
How they compare
Jamaica currently reports 99.0% against 94.0% in Late-demographic dividend, a difference of 5.0%.
That makes Jamaica's figure about 1.1 times Late-demographic dividend's.
The two have swapped places 7 times across 22 shared years of data; in 2003 it was Late-demographic dividend ahead.
Jamaica ranks 1st and Late-demographic dividend ranks 3rd of 188 countries.
Across the 3 decades both report, Jamaica averaged higher in 1 and Late-demographic dividend in 2.
Head to head by decade
| Decade | Jamaica | Late-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.3% | 89.8% | 3.5% | Late-demographic dividend |
| 2010s | 94.2% | 96.7% | 2.5% | Late-demographic dividend |
| 2020s | 96.0% | 93.5% | 2.5% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Jamaica or Late-demographic dividend?
- Jamaica, at 99.0% against 94.0% in Late-demographic dividend as of 2024.
- What is the difference in immunization, hepb3 between Jamaica and Late-demographic dividend?
- 5.0%, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Late-demographic dividend?
- 22 years are reported by both, from 2003 to 2024.
- How do Jamaica and Late-demographic dividend rank globally for immunization, hepb3?
- Jamaica ranks 1st and Late-demographic dividend ranks 3rd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.